Remove Big Data Remove Business Development Remove Containment Remove Regulation
article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

.” Kiromic’s DIAMOND is big data science meeting target identification, dramatically compressing man-years and billions of drug development dollars to develop a live drug. This press release contains forward-looking statements that involve substantial risks and uncertainties. Forward-Looking Statements.

In-Vivo 40
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. It contains the antiviral medications nirmatrelvir and ritonavir. billion in 2022. and $16,382.51

Sales 98
article thumbnail

Analysis, and Test & Measurement Equipment Companies for the Pharmaceutical Industry

Pharmaceutical Technology

Stringent government regulations and the growing need for uncompromised quality have further encouraged demand. The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.

Engineer 130